|
Product class:
|
Authorized package
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Package code:
|
1823307
|
|
Name of medicinal product:
|
Alfadexx
|
|
Active substances:
|
|
|
ATC code:
|
QH02AB02
|
|
Dosage form:
|
solution for injection
|
|
Route of administration:
|
intravenous use; subcutaneous use; intraarticular use; periarticular use; intramuscular use
|
|
Strengh:
|
2mg 1ml
|
|
Amount in package:
|
100ml 1TK
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Class of active substance:
|
|
|
Additional information:
|
|
|
Indication:
|
Horses, cattle, goats, pigs, dogs and cats:
Treatment of inflammation and allergic reactions.
Horses:
Treatment of arthritis, bursitis or tenosynovitis.
Cattle:
Treatment of primary ketosis (Acetonemia).
Induction of parturition.
Goats:
Treatment of primary ketosis (Acetonemia).
|
|
Safety features:
|
No
|
|
Summary of product characteristics (SPC):
|
 (last updated 29 September 2021)
|
|
Package information leaflet (PIL):
|
EST (last updated 29 September 2021)
|
|
Labelling:
|
(last updated 29 September 2021)
|
|
Withdrawal time:
|
Veis ja kits
Lihale ja söödavatele kudedele: 8 päeva.
Piimale: 72 tundi.
Siga
Lihale ja söödavatele kudedele: 2 päeva pärast intramuskulaarset manustamist.
Lihale ja söödavatele kudedele: 6 päeva pärast intravenoosset manustamist.
Hobune
Lihale ja söödavatele kudedele: 8 päeva.
Ei ole lubatud kasutamiseks hobustel, kelle piima tarvitatakse inimtoiduks.
|
|
Species:
|
siga, koer, veis, kits, hobune, kass
|
|
Last imported to Estonia:
|
Never imported to Estonia
|
|
Marketing authorization holder:
|
Alfasan Nederland B.V.
|
|
Marketing authorization number:
|
2308
|
|
Marketing authorization issued on:
|
29 September 2021
|
|
Marketing authorization expires on:
|
29 September 2026
|
|
Marketing authorization procedure type:
|
Decentralised
|
Entry/Changing date:
14 January 2022
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription